临床试验参与者对数据共享风险与获益的看法
该研究对美国三家学术医学中心771名正在或近期参与临床试验的受试者进行结构化调查,总体应答率79%。结果显示不足8%的受访者认为数据共享的潜在负面后果超过获益,93%愿意将数据共享给大学科学家,82%愿意共享给营利性公司科学家。
要点
- 不足8%的临床试验参与者认为数据共享的负面后果超过获益。
- 93%参与者愿意将数据共享给大学科学家,82%愿意共享给营利性公司科学家。
- 参与者最大担忧包括他人因此更不愿参加临床试验、数据用于营销及数据被盗。
核心结论
- 本研究中少数临床试验参与者对数据共享风险有强烈担忧,在具备充分安全保障的前提下,多数参与者愿意为广泛用途共享数据。
研究设计与样本
- 对美国三家学术医学中心多样化临床试验样本中的771名正在或近期参与者进行结构化调查。
- 调查通过邮件(350份完成)和诊所候诊室(421份完成)发放,总体应答率79%。
主要发现
- 不足8%的受访者认为数据共享的潜在负面后果超过获益。
- 93%的受访者非常或有些可能允许自己的数据共享给大学科学家,82%非常或有些可能共享给营利性公司科学家。
- 共享意愿随数据用途变化不大,例外是用于诉讼时愿意共享的参与者较少。
- 受访者最大担忧为数据共享可能使他人更不愿参加临床试验(37%非常或有些担忧)、数据用于营销目的(34%)、数据可能被盗(30%)。
- 对歧视(22%)和利用数据牟利(20%)的担忧较少。
关键数值与推荐
- 不足8%的受访者认为数据共享的潜在负面后果超过获益。
- 93%的受访者非常或有些可能允许自己的数据共享给大学科学家,82%非常或有些可能共享给营利性公司科学家。
- 37%的受访者非常或有些担忧数据共享可能使他人更不愿参加临床试验,34%担忧数据用于营销目的,30%担忧数据可能被盗。
- 22%的受访者担忧歧视,20%担忧利用数据牟利。
临床怎么用
- 在具备充分安全保障的前提下,可向参与者说明数据共享的广泛用途,多数参与者愿意共享数据。
- 应关注并回应参与者对他人参加临床试验意愿、营销用途和数据被盗的担忧。
- 涉及诉讼用途的数据共享可能面临较低的参与者接受度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background Sharing of participant-level clinical trial data has potential benefits, but concerns about potential harms to research participants have led some pharmaceutical sponsors and investigators to urge caution. Little is known about clinical trial participants' perceptions of the risks of data sharing. Methods We conducted a structured survey of 771 current and recent participants from a diverse sample of clinical trials at three academic medical centers in the United States. Surveys were distributed by mail (350 completed surveys) and in clinic waiting rooms (421 completed surveys) (overall response rate, 79%). Results Less than 8% of respondents felt that the potential negative consequences of data sharing outweighed the benefits. A total of 93% were very or somewhat likely to allow their own data to be shared with university scientists, and 82% were very or somewhat likely to share with scientists in for-profit companies. Willingness to share data did not vary appreciably with the purpose for which the data would be used, with the exception that fewer participants were willing to share their data for use in litigation. The respondents' greatest concerns were that data sharing might make others less willing to enroll in clinical trials (37% very or somewhat concerned), that data would be used for marketing purposes (34%), or that data could be stolen (30%). Less concern was expressed about discrimination (22%) and exploitation of data for profit (20%). Conclusions In our study, few clinical trial participants had strong concerns about the risks of data sharing. Provided that adequate security safeguards were in place, most participants were willing to share their data for a wide range of uses. (Funded by the Greenwall Foundation.).
引用
- Mello MM, Lieou V, Goodman SN, et al. Clinical Trial Participants' Views of the Risks and Benefits of Data Sharing. N Engl J Med. 2018. PMID: 29874542. doi:10.1056/NEJMsa1713258
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。